Diagnostic efficacy of Mycoplasma pneumoniae antibody and procalcitonin in children with Mycoplasma pneumonia
Abstract Background The prognosis of children with Mycoplasma pneumoniae pneumonia (MPP) is significantly impacted by the possibility of a missed or delayed diagnosis during the early stages of the illness. In this study, we assessed the potential of utilizing MP antibody and procalcitonin levels as...
Saved in:
| Main Authors: | Zhe Zhang, Boying Wu, Qijun Wang, Qiaoyi Xie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Pulmonary Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12890-025-03870-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The diagnostic value plasma procalcitonin (PCT) and serum amyloid A protein (SAA) in children with mycoplasma pneumonia
by: Wang Baoyue, et al.
Published: (2025-01-01) -
The correlation between positive rate of antibody or DNA and children’s age with suspected Mycoplasma pneumoniae infection
by: Weiguo Feng, et al.
Published: (2025-05-01) -
Analysis of the characteristics of mixed infections with Mycoplasma pneumoniae in children
by: Li Yuan, et al.
Published: (2025-03-01) -
Comparative characteristics of typical and atypical (Mycoplasma) pneumonia in children
by: T. A. Britkova, et al.
Published: (2021-07-01) -
Treatment modalities for fever duration in children with Mycoplasma pneumoniae pneumonia
by: Dayun Kang, et al.
Published: (2025-04-01)